References
- Comèl M. Ichthyosis linearis circumflexa. Dermatology. 1949;98(3):133–6.
- Netherton EW. A unique case of trichorrhexis nodosa—”bamboo hairs.” Arch Dermatol. 1958 Oct 1;78(4):483–7. doi: 10.1001/archderm.1958.01560100059009.
- Sun JD, Linden KG. Netherton syndrome: a case report and review of the literature. Int J Dermatol. 2006 Jun 20;45(6):693–7. doi: 10.1111/j.1365-4632.2005.02637.x.
- Sarri CA, Roussaki-Schulze A, Vasilopoulos Y, Zafiriou E, Patsatsi A, Stamatis C, et al. Netherton syndrome: A genotype-phenotype review. Mol Diagn Ther. 2017 Apr 30;21(2):137–52. doi: 10.1007/s40291-016-0243-y.
- Barbati F, Giovannini M, Oranges T, Lodi L, Barni S, Novembre E, et al. Netherton syndrome in children: management and future perspectives. Front Pediatr. 2021;9:645259. doi: 10.3389/fped.2021.645259.
- Herz-Ruelas ME, Chavez-Alvarez S, Garza-Chapa JI, Ocampo-Candiani J, Cab-Morales VA, Kubelis-López DE. Netherton syndrome: case report and review of the literature. Skin Appendage Disord. 2021 Aug;7(5):346–50. doi: 10.1159/000514699.
- Sprecher E, Amin S, Nielsen K, Pfendner E, Uitto J, Richard G, et al. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: Implications for mutation detection and first case of prenatal diagnosis. J. Invest. Dermatol. 2001 Aug;117(2):179–87. doi: 10.1046/j.1523-1747.2001.01389.x.
- Pontone M, Giovannini M, Filippeschi C, Oranges T, Pedaci FA, Mori F, et al. Biological treatments for pediatric Netherton syndrome. Front Pediatr. 2022 Dec 23;10:1074243. doi: 10.3389/fped.2022.1074243.
- Kostova P, Petrova G, Shahid M, Papochieva V, Miteva D, Yordanova I, et al. Netherton syndrome – A therapeutic challenge in childhood. Clin Case Rep. 2024 Apr 16;12(4):e8770. doi: 10.1002/ccr3.8770.
- Stuvel K, Heeringa JJ, Dalm VASH, Meijers RWJ, van Hoffen E, Gerritsen SAM, et al. Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency. Allergy. 2020 Jul 21;75(7):1710–20. doi: 10.1111/all.14197.
- SPINK5. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff.
https://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPINK5 . 2025. - Xu M, Shi Y, Lin L, Wang L, Zhu X, Xiong J, et al. The role of SPINK5 mutation distribution in phenotypes of Netherton syndrome. Front Genet. 2025 Jan 27;16:1475054. doi: 10.3389/fgene.2025.1475054.
- Barbieux C, Bonnet des Claustres M, Fahrner M, Petrova E, Tsoi LC, Gouin O, et al. Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses. J. Allergy Clin. Immunol. 2022 Apr;149(4):1358–72. doi: 10.1016/j.jaci.2021.08.024.
- Błażewicz I, Rustowska A, Wilkowska A, Nowicki RJ. Comèl-Netherton syndrome – case report. Przegl Dermatol. 2014;101:481–6. doi: 10.5114/dr.2014.46950
- Smith DL, Smith JG, Wong SW, deShazo RD. Netherton’s syndrome: A syndrome of elevated IgE and characteristic skin and hair findings. J. Allergy Clin. Immunol. 1995 Jan;95(1):116–23. doi: 10.1016/S0091-6749(95)70159-1
- Bittencourt M de JS, Moure ERD, Pies OTC, Mendes AD, Deprá MM, Mello ALP de. Trichoscopy as a diagnostic tool in trichorrhexis invaginata and Netherton syndrome. An Bras Dermatol. 2015 Feb;90(1):114–6. doi: 10.1590/abd1806-4841.20153011
- Geyer AS, Ratajczak P, Pol-Rodriguez M, Millar WS, Garzon M, Richard G. Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5. Dermatology. 2005;210(4):308–14. doi: 10.1159/000084755.
- Mazereeuw-Hautier J, Paller AS, O’Toole E, Dreyfus I, Bodemer C, Akiyama M, et al. Management of congenital ichthyoses: guidelines of care: Part two: 2024 update. Br J Dermatol. 2025 Jun 20;193(1):28–43. doi: 10.1093/bjd/ljaf077.
- Lucker GP, van de Kerkhof PC, van Dïjk MR, Steijlen PM. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol. 1994 Oct;131(4):546–50. doi: 10.1111/j.1365-2133.1994.tb08558.x.
- Luchsinger I, Knöpfel N, Theiler M, Bonnet des Claustres M, Barbieux C, Schwieger-Briel A, et al. Secukinumab therapy for Netherton syndrome. JAMA Dermatol. 2020 Aug 1;156(8):907–11. doi: 10.1001/jamadermatol.2020.1019
- Volc S, Maier L, Gritsch A, Aichelburg MC, Volc-Platzer B. Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl. British Journal of Dermatology. 2020 Jul 9;183(1):165–7. doi: 10.1111/bjd.18892.
- Yalcin AD. A case of Netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels. Immunopharmacol Immunotoxicol. 2016 Mar 3;38(2):162–6. doi: 10.3109/08923973.2015.1115518.
- Süßmuth K, Traupe H, Loser K, Ständer S, Kessel C, Wittkowski H, et al. Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e152–5. doi: 10.1111/jdv.16883.
- Murase C, Takeichi T, Taki T, Yoshikawa T, Suzuki A, Ogi T, et al. Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome. J Dermatol Sci. 2021 May;102(2):126–9. doi: 10.1016/j.jdermsci.2021.03.003.
- Andreasen TH, Karstensen HG, Duno M, Lei U, Zachariae C, Thyssen JP. Successful treatment with dupilumab of an adult with Netherton syndrome. Clin Exp Dermatol. 2020 Oct;45(7):915–7. doi: 10.1111/ced.14317.
- Mazereeuw-Hautier J, Paller AS, Dreyfus I, Sprecher E, O’Toole E, Bodemer C, et al. Management of congenital ichthyoses: Guidelines of care: Part one: 2024 update. Br J Dermatol. 2025 Jun 20;193(1):16–27. doi: 10.1093/bjd/ljaf076.
- Liddle J, Beneton V, Benson M, Bingham R, Bouillot A, Boullay AB, et al. A potent and selective kallikrein-5 inhibitor delivers high pharmacological activity in skin from patients with Netherton syndrome. J Invest Dermatol. 2021 Sep;141(9):2272–9. doi: 10.1016/j.jid.2021.01.029
- Zingkou E, Pampalakis G, Sotiropoulou G. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome. Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165831. doi: 10.1016/j.bbadis.2020.165831.
- Di WL, Lwin SM, Petrova A, Bernadis C, Syed F, Farzaneh F, et al. Generation and clinical application of gene-modified autologous epidermal sheets in Netherton syndrome: Lessons learned from a Phase 1 trial. Hum Gene Ther. 2019 Sep 1;30(9):1067–78. doi: 10.1089/hum.2019.049
- Salehi M, Neshati Z, Ahanchian H, Tafrishi R, Pasdar A, Safi M, et al. Hyper IgE syndromes: understanding, management, and future perspectives: a narrative review. Health Sci Rep. 2025 Mar 19;8(3). doi: 10.1002/hsr2.70497